CGTX
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
16.92M
14 days until earnings call
CLDX
Price
$20.48
Change
+$0.92 (+4.70%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
1.36B
50 days until earnings call
Ad is loading...

CGTX vs CLDX

Header iconCGTX vs CLDX Comparison
Open Charts CGTX vs CLDXBanner chart's image
Cognition Therapeutics
Price$0.41
Change-$0.00 (-0.00%)
Volume$18.19K
Capitalization16.92M
Celldex Therapeutics
Price$20.48
Change+$0.92 (+4.70%)
Volume$11.43K
Capitalization1.36B
CGTX vs CLDX Comparison Chart
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. CLDX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and CLDX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CGTX: $0.41 vs. CLDX: $19.56)
Brand notoriety: CGTX and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 34% vs. CLDX: 84%
Market capitalization -- CGTX: $16.92M vs. CLDX: $1.36B
CGTX [@Biotechnology] is valued at $16.92M. CLDX’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CGTX is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 4 TA indicator(s) are bullish while CLDX’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 4 bullish, 5 bearish.
  • CLDX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CGTX.

Price Growth

CGTX (@Biotechnology) experienced а -4.60% price change this week, while CLDX (@Biotechnology) price change was +1.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

CGTX is expected to report earnings on May 07, 2025.

CLDX is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.36B) has a higher market cap than CGTX($16.9M). CLDX YTD gains are higher at: -22.596 vs. CGTX (-41.452). CGTX has higher annual earnings (EBITDA): -33.98M vs. CLDX (-171.06M). CLDX has more cash in the bank: 756M vs. CGTX (22M). CGTX has less debt than CLDX: CGTX (580K) vs CLDX (3.09M). CLDX has higher revenues than CGTX: CLDX (9.98M) vs CGTX (0).
CGTXCLDXCGTX / CLDX
Capitalization16.9M1.36B1%
EBITDA-33.98M-171.06M20%
Gain YTD-41.452-22.596183%
P/E RatioN/AN/A-
Revenue09.98M-
Total Cash22M756M3%
Total Debt580K3.09M19%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXCLDX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 6 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFPGX24.64N/A
N/A
Parnassus Growth Equity Institutional
MGRCX39.88N/A
N/A
MFS International Growth C
THPBX23.38N/A
N/A
BNY Mellon Balanced Opportunity J
PDARX11.35N/A
N/A
Principal Diversified Real Asset R6
VIPAX28.76N/A
N/A
Voya Index Plus LargeCap Port ADV

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and VTVT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and VTVT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
-4.20%
VTVT - CGTX
31%
Poorly correlated
-2.54%
CLDX - CGTX
30%
Poorly correlated
-5.37%
BRCTF - CGTX
28%
Poorly correlated
N/A
BCRX - CGTX
28%
Poorly correlated
-4.03%
NNVC - CGTX
26%
Poorly correlated
-8.66%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-5.37%
BEAM - CLDX
44%
Loosely correlated
-9.80%
DNLI - CLDX
43%
Loosely correlated
-10.43%
PRTA - CLDX
43%
Loosely correlated
-4.26%
KYMR - CLDX
43%
Loosely correlated
+0.40%
AXON - CLDX
43%
Loosely correlated
-2.08%
More